Evidence map›Paper›PMID 26756582›Full record

ArticleMacromolecular bioscience2016

Maleimide-Functionalized Poly(2-Oxazoline)s and Their Conjugation to Elastin-Like Polypeptides.

Jonas F Nawroth, Jonathan R McDaniel, Ashutosh Chilkoti, Rainer Jordan, Robert Luxenhofer

Abstract read
In one paragraph

Article in Macromolecular bioscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Determination ofRoyal Society open science · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Responsive Hybrid (Poly)peptide-Polymer Conjugates.Journal of materials chemistry. B · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jonas F NawrothDepartment Chemie, Technische Universität Dresden, Mommsenstr. 4, 01069, Dresden, Germany.
Jonathan R McDanielDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708-0281, USA.
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, Durham, NC, 27708-0281, USA.
Rainer JordanDepartment Chemie, Technische Universität Dresden, Mommsenstr. 4, 01069, Dresden, Germany.
Robert LuxenhoferDepartment Chemie, Technische Universität Dresden, Mommsenstr. 4, 01069, Dresden, Germany.

Funding

ELASTIN FUSION PROTEINSR01GM061232 · NIGMS · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2000 to 2017
$4.6M
Thermally Targeted Drug Delivery by Elastin BiopolymersR01EB000188 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2002 to 2015
$3.9M
Thermally Triggered Multivalent Targeting of TumorsR01EB007205 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2007 to 2015
$2.7M
NIBIB NIH HHS R01 EB000188NIBIB NIH HHS R01 EB007205NIGMS NIH HHS R01 GM061232NIGMS NIH HHS R01 GM61232
6 · The paper itself

Abstract

The design of drug delivery systems capable of efficiently delivering poorly soluble drugs to target sites still remains a major challenge. Such materials require several different functionalities; typically, these materials should be biodegradable and nontoxic, nonimmunogenic, responsive to their environment, and soluble in aqueous solution while retaining the ability to solubilize hydrophobic drugs. Here, a polypeptide-polymer hybrid of elastin-like polypeptides (ELPs) and poly(2-oxazoline)s (POx) is reported. This paper describes the chemical synthesis, physical characteristics, and drug loading potential of these novel hybrid macromolecules. A novel method is introduced for terminal functionalization of POx with protected maleimide moieties. Following recovery of the maleimide group via a retro Diels-Alder reaction, the consecutive Michael addition of thiol-functionalized ELPs yields the desired protein-polymer conjugate. These conjugates form nanoparticles in aqueous solution capable of solubilizing the anti-cancer drug paclitaxel with up to 8 wt% loading.

Indexed as

ElastinMaleimidesOxazolesRecombinant ProteinsElastinmaleimideMaleimidesOxazolespoly(2-oxazoline)Recombinant Proteinsbioconjugationdrug delivery systemselastin-like polypeptidespaclitaxelring-opening polymerization

Identifiers

PMID26756582
PMCPMC5320936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.